venBio Select Advisor »

Akero Therapeutics shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2025-09-30 $188M 4.0M 47.48
2025-06-30 $187M 3.5M 53.36
2023-09-30 $28M 556k 50.58

More positions owned by venBio Select Advisor

Ascendis Pharma Sponsored ADR (ASND)
United Therapeutics Corp Common (UTHR)
Madrigal Pharmaceuticals Common (MDGL)
Argenx Se Sponsored ADR (ARGX)
Krystal Biotech Common (KRYS)
Arrowhead Pharmaceuticals Common (ARWR)
Kymera Therapeutics Common (KYMR)
Merus N V Common (MRUS)
Avidity Biosciences Common (RNA)
Apellis Pharmaceuticals Common (APLS)
Centessa Pharmaceuticals Sponsored Adr (CNTA)
Uniqure Nv Common (QURE)
Xenon Pharmaceuticals Common (XENE)
Akero Therapeutics Common (AKRO)
Vera Therapeutics Common (VERA)

View all positions for venBio Select Advisor

Top funds holding Akero Therapeutics

Henderson Group
General Atlantic
BlackRock
Rtw Investments
Vanguard Group
Wellington Management Company
Deep Track Capital
venBio Select Advisor
State Street Corporation
Bellevue Group
Point72 Asset Management
Alkeon Capital Management
Geode Capital Management
Alliancebernstein
Marshall Wace

View all funds holding Akero Therapeutics